Osteoarthritis of the hip is a degenerative joint disease that, besides being painful, also has a negative impact on mobility. An affected joint can be surgically replaced with an artificial prosthesis to alleviate pain and enhance mobility and quality of life. However, when the replacement hip is forced from its normal position-a so-called dislocation-these patients frequently experience injuries, undermining their trust in the artificial joint. Depending on the trauma that caused the dislocation, it may even be necessary to replace the prosthesis.
In patients with severe varus deformity of the knee, mini-midvastus total knee arthroplasty had no adverse clinical outcomes as a result of poor implant position, according to study results.
Injecting a newer long-acting numbing medicine called liposomal bupivacaine into the tissue surrounding the knee during surgery may provide a faster recovery and higher patient satisfaction, a new study has found.
10-million Americans have osteoporosis and 18-million more are at risk. The bone disease leads to an increase in fractures in the hip, spine and wrist accounting for one-point-five million painful fractures each year and one woman's harrowing story of recovery is inspiring.
Researchers from Denmark have uncovered a potential link between oral contraceptive use and instances of ACL injuries that required surgical intervention in women. The researchers evaluated 4,497 women who were treated operatively for an ACL injury between July 2005 and December 2011 and 8,858 age-matched, uninjured controls.
After a knee replacement, there's no place like home for your physical therapy - or at least home may be just as good a place as a clinic to do your exercises. In a new study, knee replacement patients who followed a six-week, monitored exercise program at home showed similar progress to those who were in regular outpatient rehabilitation programs.
Every year, 330-thousand Americans undergo surgery to replace hip joints that have been damaged by age or overuse. After surgery most patients can go back to their normal activities but no running, no jumping and no high impact sports for some people who have been very physically active. Now, new research shows hip resurfacing may be the better option to get them back on their feet.
Use of platelet-rich plasma had no evident effect on patients undergoing total knee arthroplasty, according to study results. Researchers randomly assigned 40 patients who were scheduled to undergo primary unilateral total knee arthroplasty (TKA) to be treated with platelet-rich plasma (PRP) or to a control group. Patients' hemoglobin (Hb) and hematocrit levels were documented before surgery and again on days 1, 7, 14 and 28 postoperatively, and estimated blood loss was calculated. The researchers also recorded and assessed the patients' C-reactive protein (CRP) levels, range of motion, pain levels, knee extension muscle strength, knee swelling, circumference differences, Knee Society Knee Score, Knee Society Functional Score and KOOS at various time points throughout the study.
EOS imaging obtains FDA approval for hipEOS, the first 3D stereoradiographic planning software for hip arthroplasty
EOS imaging, the pioneer in orthopaedic 2D/3D imaging, announced today that the U.S. Food and Drug Administration has approved hipEOS, a 3D hip arthroplasty planning software based on EOS stereo-radiographic 2D/3D imaging. hipEOS is the first offering of a software portfolio associated with the EOS imaging system. Developed by OneFit medical, an EOS imaging group company, the software enables surgeons to perform, using EOS unique stereo-radiographic 2D/3D low dose images, pre-surgical planning including hip implant selection and virtual positioning in functional, weight-bearing 3D. The software takes full advantage of the bias-free, real size 3D patient anatomical information obtained from the EOS exam to help physicians define implant size and visualize pre-operatively the restoration expected from a total hip arthroplasty prior to surgery. hipEOS received a CE Mark in March 2014.
EOS Imaging recently announced the FDA has approved hipEOS, the company's new 3-D planning software for total hip arthroplasty procedures. Designed with the intent to improve preoperative planning, hipEOS allows surgeons to test everything from hip implant selection to positioning in functional, weight-bearing 3-D based on the anatomical data specific to each patient. These data stem from the company's stereo-radiographic 2-D/3-D imaging and represent the first instance of a software portfolio offered with the EOS imaging system, according to a company press release. This improvement in planning via hipEOS is believed to aid surgeons in the accuracy of the restoration they anticipate following THA.